Simulations Plus Inc. (SLP)

19.15
0.15 0.79
NASDAQ : Technology Services
Prev Close 19.00
Open 19.05
Day Low/High 19.00 / 19.25
52 Wk Low/High 11.45 / 19.55
Volume 11.75K
Avg Volume 51.70K
Exchange NASDAQ
Shares Outstanding 17.33M
Market Cap 329.19M
EPS 0.30
P/E Ratio 53.19
Div & Yield 0.24 (1.19%)

Latest News

Simulations Plus Announces Employee Bonuses

null

SLP Ex-Dividend Reminder - 4/24/18

Looking at the universe of stocks we cover at Dividend Channel, on 4/24/18, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.06, payable on 5/2/18.

Simulations Plus Sets Date For 2nd Quarter 2018 Earnings Release And Conference Call

Simulations Plus Sets Date For 2nd Quarter 2018 Earnings Release And Conference Call

Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the second quarter of its 2018 fiscal year, the period ended February 28, 2018, on Monday, April 9, 2018.

Simulations Plus Launches Version 2.0 Of PKPlus™

Simulations Plus Launches Version 2.0 Of PKPlus™

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical development from earliest discovery through all phases of clinical trials, today...

Simulations Plus Subsidiary Cognigen Releases KIWI Version 2

Simulations Plus Subsidiary Cognigen Releases KIWI Version 2

Cognigen Corporation, a Simulations Plus company (NASDAQ: SLP) and a leading provider of population pharmacokinetic and pharmacodynamic modeling and simulation services, today announced that it has released Version 2 of its...

SLP Ex-Dividend Reminder - 1/25/18

SLP Ex-Dividend Reminder - 1/25/18

Looking at the universe of stocks we cover at Dividend Channel, on 1/25/18, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.06, payable on 2/2/18.

Simulations Plus Announces Quarterly Cash Dividend Of $0.06 Per Share

Simulations Plus Announces Quarterly Cash Dividend Of $0.06 Per Share

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all stages of pharmaceutical discovery and development, today announced that its board of directors...

DILIsym Services Inc., A Simulations Plus Company, Releases DILIsym® Version 7A

DILIsym Services Inc., A Simulations Plus Company, Releases DILIsym® Version 7A

DILIsym Service, Inc., a Simulations Plus company (NASDAQ: SLP) and a leading provider of simulation and modeling software for pharmaceutical safety and efficacy, today announced that it has released Version 7A of its...

Simulations Plus Reports First Quarter FY2018 Financial Results

Simulations Plus Reports First Quarter FY2018 Financial Results

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all stages of pharmaceutical discovery and development from the earliest discovery through all...

Simulations Plus Sets Date For 1st Quarter 2018 Earnings Release And Conference Call

Simulations Plus Sets Date For 1st Quarter 2018 Earnings Release And Conference Call

Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the first quarter of its 2018 fiscal year on Tuesday, January 9, 2018.

Simulations Plus Releases ADMET Predictor™ Version 8.5

Simulations Plus Releases ADMET Predictor™ Version 8.5

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, chemicals, and consumer goods industries, today announced that it has released version 8.

Simulations Plus To Present At LD Micro 10th Annual Main Event On December 6

Simulations Plus To Present At LD Micro 10th Annual Main Event On December 6

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today announced that chairman and chief executive officer, Walt Woltosz, will present at the 10th annual LD...

Simulations Plus Reports FY2017 And Fourth Quarter FY2017 Financial Results

Simulations Plus Reports FY2017 And Fourth Quarter FY2017 Financial Results

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2017 fiscal year (FY17) and fourth quarter (4Q17) ended August...

Ex-Div Reminder for Simulations Plus (SLP)

Ex-Div Reminder for Simulations Plus (SLP)

Looking at the universe of stocks we cover at Dividend Channel, on 11/10/17, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.06, payable on 11/20/17.

Simulations Plus Sets Date For 4th Quarter And Fiscal Year 2017 Earnings Release And Conference Call

Simulations Plus Sets Date For 4th Quarter And Fiscal Year 2017 Earnings Release And Conference Call

Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file Form 10-K for the 2017 fiscal year ended August 31, 2017, with the U.

Simulations Plus Announces Quarterly Cash Dividend Of $0.06 Per Share

Simulations Plus Announces Quarterly Cash Dividend Of $0.06 Per Share

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical...

Simulations Plus Reports Preliminary Revenues For Fourth Quarter And Fiscal Year 2017

Simulations Plus Reports Preliminary Revenues For Fourth Quarter And Fiscal Year 2017

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical...

Simulations Plus Announces Senior Management Changes

Simulations Plus Announces Senior Management Changes

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced changes in its senior management structure.

Simulations Plus Releases MembranePlus™ Version 2

Simulations Plus Releases MembranePlus™ Version 2

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, chemicals, and consumer goods industries, today announced that it has released version 2 of its in...

DILIsym Services Inc., A Simulations Plus Company, Releases DILIsym® Version 6A

DILIsym Services Inc., A Simulations Plus Company, Releases DILIsym® Version 6A

DILIsym Services Inc., a Simulations Plus company (NASDAQ: SLP) and a leading provider of simulation and modeling software for pharmaceutical safety and efficacy, today announced that it has released Version 6A of its...

SLP Ex-Dividend Reminder - 7/26/17

SLP Ex-Dividend Reminder - 7/26/17

Looking at the universe of stocks we cover at Dividend Channel, on 7/26/17, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.05, payable on 8/4/17.

Market Can't Sustain Upside Push

Market Can't Sustain Upside Push

Catching a decent wave more about luck than skill.

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, today announced that its board of...

Simulations Plus Reports Third Quarter FY2017 Financial Results

Simulations Plus Reports Third Quarter FY2017 Financial Results

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical...

Simulations Plus Sets Date For 3rd Quarter 2017 Earnings Release And Conference Call

Simulations Plus Sets Date For 3rd Quarter 2017 Earnings Release And Conference Call

Simulations Plus, Inc. (Nasdaq:SLP) announced today that it expects to file its quarterly report on Form 10-Q for the third quarter of its 2017 fiscal year, the period ended May 31, 2017, on Monday, July 10, 2017.

Simulations Plus Reports Record Preliminary Revenues For Third Quarter FY2017

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the third quarter of its fiscal year 2017,...

Simulations Plus Closes Acquisition Of DILIsym Services, Inc.

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that the Stock Purchase Agreement (the "Agreement") with DILIsym...

Simulations Plus To Present At The 7th Annual LD Micro Invitational

Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, announced that it will be presenting at the 7 th Annual LD...

TheStreet Quant Rating: A- (Buy)